Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
4.76%
End price
30.07.24
€5.50
Summary
This prediction ended on 30.07.24 with a price of €5.50. The BUY prediction by StockNews_com finished with a performance of 4.76%. StockNews_com has a follow-up prediction for Vanda Pharmaceuticals where he still thinks Vanda Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Vanda Pharmaceuticals | 0.476% | 0.476% | -2.765% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten